Related Experiment Video
Updated: Mar 16, 2026

Yeast As a Chassis for Developing Functional Assays to Study Human P53
Published on: August 4, 2019
Lysine methylation represses p53 activity in teratocarcinoma cancer cells
Jiajun Zhu1, Zhixun Dou2, Morgan A Sammons2
1Epigenetics Program, Cell and Developmental Biology, Perelman School of Medicine, University of Pennsylvania, Philadelphia, PA 19104; Biomedical Graduate Studies, Perelman School of Medicine, University of Pennsylvania, Philadelphia, PA 19104;
Abstract:
TP53 (which encodes the p53 protein) is the most frequently mutated gene among all human cancers, whereas tumors that retain the wild-type TP53 gene often use alternative mechanisms to repress the p53 tumor-suppressive function. Testicular teratocarcinoma cells rarely contain mutations in TP53, yet the transcriptional activity of wild-type p53 is compromised, despite its high expression level. Here we report that in the teratocarcinoma cell line NTera2, p53 is subject to lysine methylation at its carboxyl terminus, which has been shown to repress p53's transcriptional activity. We show that reduction of the cognate methyltransferases reactivates p53 and promotes differentiation of the NTera2 cells. Furthermore, reconstitution of methylation-deficient p53 mutants into p53-depleted NTera2 cells results in elevated expression of p53 downstream targets and precocious loss of pluripotent gene expression compared with re-expression of wild-type p53. Our results provide evidence that lysine methylation of endogenous wild-type p53 represses its activity in cancer cells and suggest new therapeutic possibilities of targeting testicular teratocarcinoma.
Insights
Wild-type TP53 (tumor protein 53) activity is repressed by lysine methylation in testicular teratocarcinoma cells. Reducing methyltransferases reactivates p53, promoting cell differentiation and suggesting new therapeutic targets.
Area of Science:
- Oncology
- Molecular Biology
- Epigenetics
Background:
- TP53 mutations are common in cancers, but wild-type TP53 function is also repressed in some tumors.
- Testicular teratocarcinoma cells often retain wild-type TP53, yet p53 activity is suppressed despite high expression.
Purpose of the Study:
- To investigate the mechanism of wild-type p53 repression in testicular teratocarcinoma.
- To explore the role of post-translational modifications in p53 activity within these cancer cells.
Main Methods:
- Analysis of p53 lysine methylation in the NTera2 teratocarcinoma cell line.
- Manipulation of methyltransferase levels and expression of wild-type and mutant p53.
- Assessment of p53 downstream target gene expression and cellular differentiation.
Main Results:
- Endogenous wild-type p53 in NTera2 cells undergoes lysine methylation, repressing its transcriptional activity.
- Depletion of methyltransferases reactivates p53 and induces NTera2 cell differentiation.
- Methylation-deficient p53 mutants enhance p53 target gene expression and accelerate differentiation compared to wild-type p53.
Conclusions:
- Lysine methylation of wild-type p53 is a key mechanism for repressing its tumor-suppressive function in testicular teratocarcinoma.
- Targeting p53 methylation presents a potential therapeutic strategy for testicular cancers.
More Related Videos
10:26Toxicological Assays for Testing Effects of an Epigenetic Drug on Development, Fecundity and Survivorship of Malaria Mosquitoes
Published on: January 16, 2015
10:09Isolation and Cultivation of Neural Progenitors Followed by Chromatin-Immunoprecipitation of Histone 3 Lysine 79 Dimethylation Mark
Published on: January 26, 2018
Related Concept Videos
Abnormal Proliferation
Epigenetic Regulation
Epigenetic Regulation
X-chromosome...
Loss of Tumor Suppressor Gene Functions
When the tumor suppressor genes develop mutations or are lost, cells start growing out of control, leading to cancer. However, a single functional copy of the tumor suppressor gene is enough for the cells to maintain their normal functions and cell...
Negative Regulator Molecules
Replicative Cell Senescence